A Look At Omega Healthcare Investors (OHI) Valuation After Its Solid First Quarter Earnings And Dividend Hold

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.

Omega Healthcare Investors (OHI) just posted first quarter results that showed higher revenue and net income year over year, while keeping its US$0.67 quarterly dividend intact and moving ahead with the planned CommuniCare portfolio sale.

See our latest analysis for Omega Healthcare Investors.

Following the Q1 update, Omega Healthcare Investors’ share price is at US$46.13, with a 1-year total shareholder return of 38.1% and a 5-year total shareholder return of 94.0%. This suggests that momentum has built over time rather than faded recently.

If you are reassessing income focused real estate and healthcare exposure after these results, it might also be worth widening the search to other income ideas through 12 dividend fortresses

With OHI trading at US$46.13, showing an intrinsic value gap of around 50% and sitting roughly 8% below the average analyst price target, you have to ask yourself: is there still an opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 6.6% Undervalued

Omega Healthcare Investors' most followed valuation narrative points to a fair value of $49.38 against the current $46.13 share price, leaving a modest implied upside that hinges on how its earnings profile evolves.

Omega's disciplined balance sheet management and opportunistic use of both debt and equity (with a low leverage ratio at decade lows and largely fixed-rate debt) position the company to pursue high-yield acquisitions and portfolio expansion at accretive rates, supporting long-term AFFO and net earnings growth.

Read the complete narrative.

Want to see what is built into that earnings path? The narrative leans heavily on margins, modest revenue assumptions, and a richer profit multiple. Curious which inputs really move that $49.38 fair value call.

Result: Fair Value of $49.38 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, risks around tenant credit, including the Genesis bankruptcy process, as well as exposure to U.K. regulation and currency swings, could still unsettle that valuation story.

Find out about the key risks to this Omega Healthcare Investors narrative.

Next Steps

With both risks and rewards in play, do you want to simply accept the headline view, or would you prefer to stress test it yourself using the 5 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop with just one stock, you risk missing opportunities that could fit your goals even better. Broaden your watchlist with a few focused screens instead.

Story Continues

Spot potential mispricings by scanning for companies that combine quality metrics with a discount to intrinsic value through the 51 high quality undervalued stocks. Strengthen your income stream by hunting for reliable payers screened as 12 dividend fortresses. Prioritise capital protection by filtering for companies assessed as 71 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OHI.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments